World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 16 December 2017
Main ID:  NCT02237833
Date of registration: 08/09/2014
Prospective Registration: Yes
Primary sponsor: Karl-Andre Wian
Public title: Cerebral Oxygenation in Septic Patients Using Vasopressors - the Conscious Study CONSCIOUS
Scientific title: Cerebral Oxygenation in Septic Patients Using Vasopressors - The Conscious Study
Date of first enrolment: February 2015
Target sample size: 15
Recruitment status: Terminated
URL:  https://clinicaltrials.gov/show/NCT02237833
Study type:  Observational
Study design:   
Phase:  N/A
Countries of recruitment
Norway
Contacts
Name:     Karl-Andre Wian, cand.med.
Address: 
Telephone:
Email:
Affiliation:  Syekhuset Vestfold HF
Key inclusion & exclusion criteria

Inclusion Criteria:

- 18 years or older

- Septic shock patients in ICU department requiring vasopressor therapy

Exclusion Criteria:

- Damage to the frontal lobes corresponding to the area where SCO2 is monitored

- Patients in pharmacological studies

- Patients with known intracranial vascular anomalies or cerebral aneurysms

- Patients where vasoactive medication is started before cerebral oxymetry is
established

- Patients with known neurological disease

- Patients with undergone cerebral insult, transient ischemic attack or carotid stenosis

- Patients who have been resuscitated after cardiac arrest in connection with this
hospital stay

- Patients with a body temperature below 35 degrees Celsius when establishing monitoring



Age minimum: 18 Years
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Septic Shock
Intervention(s)
Primary Outcome(s)
Number of minutes of SCO2-values lower than 50 or reduced by 20% during 24 hours [Time Frame: 24 hours]
Secondary Outcome(s)
Fluid balance [Time Frame: 24 hours]
Incidence of organ failure [Time Frame: Discharge from ICU, expected 5 days at average]
Length of stay in hospital [Time Frame: Discharge from hospital, expected 10 days at average]
Length of stay in ICU [Time Frame: Discharge from ICU, expected 5 days at average]
Incidence of acute myocardial infarction [Time Frame: Hospital discharge, expected 12 days at average]
Use of vasopressors/inotropes [Time Frame: Discharge from ICU, expected 5 days at average]
Secondary ID(s)
2014/194 REK
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history